{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:03:18Z","timestamp":1765976598569,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>X-linked agammaglobulinemia (XLA) is a hereditary immune disorder that predisposes patients to frequent and severe bacterial infections caused by encapsulated bacteria (such as Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae). Otitis media, sinusitis, and pneumonia are common complications of XLA that require prompt diagnosis and treatment. Cytomegaloviruses (CMV) cause widespread and severe infections in immunocompromised individuals, affecting the respiratory tract, and consequently, leading to pneumonia, which is associated with a high mortality rate. However, CMV-induced pneumonia is rarely reported in patients with XLA. This case study details a 37-year-old male patient with XLA presenting with fever, productive cough, and dyspnea. The patient was diagnosed with CMV pneumonia and recovered after treatment. To the best of our knowledge, this is the first reported case of CMV pneumonia in a patient with XLA in Taiwan. This case study emphasizes that CMV pneumonia in patients with XLA is a treatable condition if diagnosed promptly, and that a shorter duration of treatment with the antiviral agent, in combination with immunoglobulin replacement therapy, can resolve symptoms.<\/jats:p>","DOI":"10.3390\/medicina58101457","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T02:29:46Z","timestamp":1665973786000},"page":"1457","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report"],"prefix":"10.3390","volume":"58","author":[{"given":"Yao-Xian","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Mackay Memorial Hospital, Taipei 104, Taiwan"},{"name":"Department of Pediatrics, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-1535","authenticated-orcid":false,"given":"Shyh-Dar","family":"Shyur","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Mackay Memorial Hospital, Taipei 104, Taiwan"},{"name":"Mackay Medical College, New Taipei City 25245, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1164\/ajrccm.159.4.9807067","article-title":"Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia","volume":"159","author":"Kainulainen","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14785\/lpsn-2014-0015","article-title":"Atypical presentation and manifestations in X-linked agammaglobulinemia patients with novel BTK mutations","volume":"2","author":"Nahuma","year":"2015","journal-title":"LymphoSign J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lim, L.M., Chang, J.M., Wang, I.F., Chang, W.C., Hwang, D.Y., and Chen, H.C. (2013). Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient. BMC Pediatr., 13.","DOI":"10.1186\/1471-2431-13-150"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0091-6749(95)70138-9","article-title":"X-linked agammaglobulinemia presenting as transient hypogammaglobulinemia of infancy","volume":"95","author":"Kornfeld","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mpd.2001.115970","article-title":"A mutation in Bruton\u2019s tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency","volume":"139","author":"Wood","year":"2001","journal-title":"J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/clim.2001.5024","article-title":"A case of X-linked agammaglobulinemia diagnosed in adulthood","volume":"99","author":"Stewart","year":"2001","journal-title":"Clin. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","first-page":"e7884","article-title":"X-linked agammaglobulinemia presenting with multiviral pneumonia","volume":"12","author":"Saindon","year":"2020","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"E1207","DOI":"10.21037\/jtd.2016.10.12","article-title":"Bruton\u2019s agammaglobulinemia in an adult male due to a novel mutation: A case report","volume":"8","author":"Xu","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1128\/JVI.01554-13","article-title":"Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells","volume":"87","author":"Cayatte","year":"2013","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2018.09.003","article-title":"New therapies for human cytomegalovirus infections","volume":"159","author":"Britt","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gugliesi, F., Coscia, A., Griffante, G., Galitska, G., Pasquero, S., Albano, C., and Biolatti, M. (2020). Where do we stand after decades of studying human Cytomegalovirus?. Microorganisms, 8.","DOI":"10.3390\/microorganisms8050685"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e230229","DOI":"10.1136\/bcr-2019-230229","article-title":"Human cytomegalovirus pneumonia in an immunocompetent patient: A very uncommon but treatable condition","volume":"12","author":"Waqas","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bmt.1704505","article-title":"Management of CMV infections: Recommendations from the infectious diseases working party of the EBMT","volume":"33","author":"Ljungman","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaip.2020.08.016","article-title":"Increased respiratory viral detection and symptom burden among patients with primary antibody deficiency: Results from the BIPAD study","volume":"9","author":"Ponsford","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1089\/vim.2016.0151","article-title":"Interaction of immunoglobulin with cytomegalovirus-infected cells","volume":"30","author":"Aiba","year":"2017","journal-title":"Viral Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcv.2017.03.005","article-title":"Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization","volume":"90","author":"Schampera","year":"2017","journal-title":"J. Clin. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/bmt.2017.11","article-title":"CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Iglesias","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/infdis\/jix048","article-title":"Cytomegalovirus (CMV) DNA quantitation in bronchoalveolar lavage fluid from hematopoietic stem cell transplant recipients with CMV pneumonia","volume":"215","author":"Boeckh","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.waojou.2019.100018","article-title":"X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world","volume":"12","author":"Abramova","year":"2019","journal-title":"World Allergy Organ. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.anai.2013.06.013","article-title":"Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: Review of the current data","volume":"111","author":"Ballow","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/cei.12866","article-title":"Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: A Phase 2\/3 study in Europe in patients with primary immunodeficiencies","volume":"187","author":"Borte","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.waojou.2019.100068","article-title":"Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: A systematic review and meta-analysis of clinical studies","volume":"12","author":"Shrestha","year":"2019","journal-title":"World Allergy Organ. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaci.2010.04.016","article-title":"Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia","volume":"126","author":"Kainulainen","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaci.2013.12.1085","article-title":"Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation","volume":"133","author":"Lougaris","year":"2014","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/10\/1457\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:54:53Z","timestamp":1760144093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/10\/1457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["medicina58101457"],"URL":"https:\/\/doi.org\/10.3390\/medicina58101457","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2022,10,15]]}}}